Technicals for J. B. Chemicals & Pharmaceuticals Limited
The PSAR for JBCHEPHARM continues to indicate a bearish outlook, reinforcing a...
The PSAR for JBCHEPHARM continues to indicate a bearish outlook, reinforcing a...
JBCHEPHARM's current ratio of 3.041, indicating that the company can meet its...
The list of all important regulatory filings for J. B. Chemicals &...
The article discusses how AI technologies are leveraging digital footprints to provide...
An analysis of why European banks continue to report strong profits despite...
A comprehensive analysis of the OECD's warning regarding the systemic risks posed...
Published | Title | Summary |
---|---|---|
2025-05-14 19:47:32 | Dividend | JB Chemicals & Pharmaceuticals Limited has informed the Exchange that... |
2025-02-04 19:15:42 | Dividend | JB Chemicals & Pharmaceuticals Limited has informed the Exchange that... |
2025-01-24 18:04:26 | Board Meeting Intimation | JB Chemicals & Pharmaceuticals Limited has informed the Exchange about... |
2024-07-26 18:02:23 | Board Meeting Intimation | JB CHEMICALS & PHARMACEUTICALS LIMITED has informed the Exchange about... |
Lists of companies in NSE500 with the best and the worst technicals...
Lists of companies in NSE500 with the best and the worst fundamentals...
List of the latest important filings for NSE500....
Analysts are raising red flags about the $1.7 trillion private credit market,...
An analysis of the professions that are expected to remain resilient in...
An in-depth examination of the factors contributing to the U.S. dollar's multi-year...